跳至主要内容
临床试验/EUCTR2006-003515-44-ES
EUCTR2006-003515-44-ES进行中(未招募)不适用

Cardioprotective effect of sevoflurane versus propofol used during anesthesia and the postoperative period in patients undergoing coronary bypass surgery. Impact on critical care unit stay. A double-blind, randomized, controlled, prospective clinical study.Efecto cardioprotector del sevoflurano frente al propofol, utilizados durante la anestesia y el periodo postoperatorio en pacientes sometidos a cirugía de bypass coronario. Repercusión sobre la estancia en la unidad de críticos. Estudio clínico, prospectivo, controlado, randomizado y doble ciego.

FRANCISCO JAVIER BELDA0 个研究点开始时间: 2010年3月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Signed informed consent (patient or relatives)
  • 2. Aged 18 years or older
  • 3. Minimum postoperative sedation of 4 hours
  • 4. Patients scheduled for elective coronary surgery.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Prior coronary or valvular surgery
  • 2. Combined surgery (simultaneous carotid endartectomy, valvular repair, left ventricular aneurysmectomy)
  • 3. Unstable angina
  • 4. Valvular insufficiency
  • 5. Myocardial infarction in the last 6 weeks
  • 6. Active congestive heart failure
  • 7. Hemodynamic instability requiring pharmacologic or mechanical support
  • 8. Renal dysfunction: Creatinine > 1.5 mg/dL
  • 9. Hepatic dysfunction: GOT, GPT > 150 U/L
  • 10. Severe chronic obstructive pulmonary disease (FEV1 < 50% or < 2 L)
  • 11. History of chronic enolism or neurological disease
  • 12. Pregnant or lactating women

研究者

发起方
FRANCISCO JAVIER BELDA

相似试验